BIIB
Biogen Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$220.89
−1.61%Forward multiples
Based on analyst estimates
- P/E forward
- 16.66x
- P/E 2026E
- 17.67x
- P/E 2027E
- 13.33x
- P/E 2028E
- 11.81x
- P/S forward
- 3.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.89x
- PEG TTM
- 0.29x
- Price / book
- 1.73x
- Price / sales
- 3.28x
- Price / cash flow
- 11.34x
Enterprise value
- Enterprise value
- $39.7B
- EV / sales
- 3.99x
- EV / EBITDA
- 23.76x
- EV / EBIT
- 31.21x
- Market cap
- $32.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026